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Methodology for sampling women at high
maternal risk in administrative data
Jennifer Vanderlaan1* , Anne Dunlop1, Roger Rochat2, Bryan Williams1 and Susan E. Shapiro1
Abstract
Background: In population level studies, the conventional practice of categorizing women into low and high
maternal risk samples relies upon ascertaining the presence of various comorbid conditions in administrative data.
Two problems with the conventional method include variability in the recommended comorbidities to consider
and inability to distinguish between maternal and fetal risks. High maternal risk sample selection may be improved
by using the Obstetric Comorbidity Index (OCI), a system of risk scoring based on weighting comorbidities
associated with maternal end organ damage. The purpose of this study was to compare the net benefit of using
OCI risk scoring vs the conventional risk identification method to identify a sample of women at high maternal risk
in administrative data.
Methods: This was a net benefit analysis using linked delivery hospitalization discharge and vital records data for
women experiencing singleton births in Georgia from 2008 to 2012. We compared the value identifying a sample
of women at high maternal risk using the OCI score to the conventional method of dichotomous identification of
any comorbidities. Value was measured by the ability to select a sample of women designated as high maternal risk
who experienced severe maternal morbidity or mortality.
Results: The high maternal risk sample created with the OCI had a small but positive net benefit (+ 0.6), while the
conventionally derived sample had a negative net benefit indicating the sample selection performed worse than
identifying no woman as high maternal risk.
Conclusions: The OCI can be used to select women at high maternal risk in administrative data. The OCI provides
a consistent method of identification for women at risk of maternal morbidity and mortality and avoids
confounding all obstetric risk factors with specific maternal risk factors. Using the OCI may help reduce
misclassification as high maternal risk and improve the consistency in identifying women at high maternal risk in
administrative data.
Keywords: Maternal morbidity, Pregnancy, high-risk, Comorbidity, International classification of diseases, Risk
assessment
Background
As part of a project examining the effects of regionalization
of maternal care, we realized there was no standard for iden-
tifying a sample of women likely to be transferred to higher
acuity care based on risks to maternal health. Though vari-
ous research definitions of obstetric risk exist, these often re-
flect fetal risks or are based on maternal social and medical
conditions that do not necessarily indicate a need for higher
acuity care to protect maternal health [1–3]. Clinical
guidelines, though useful in practice, may not be appropriate
for research sample selection because they 1) do not differ-
entiate between maternal and fetal risk, 2) focus on identify-
ing women at low risk rather than defining high maternal
risk, and 3) rely on clinical information not available in ad-
ministrative data [4, 5]. We were concerned that any con-
ventional sample selection method we used would
overestimate the clinical maternal risk, causing misclassifica-
tion bias in our study.
In 2013, Bateman and colleagues proposed a comor-
bidity summary measure weighted specifically for associ-
ation between maternal comorbidities and end organ
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damage or mortality during delivery hospitalization [6].
A list of the included comorbidities is available in
Table2. The obstetric comorbidity index (OCI) improves
the precision of risk identification by assigning weight to
each condition to account for the complexity of multiple
conditions. Comorbidity summary scores, such as the
OCI, have been suggested as indicators of clinical prog-
nosis because of their predictive ability [7]. Because of
this, we reasoned that using the OCI to categorize ma-
ternal risk may provide a way to simulate clinical deci-
sion making to select a sample of women in need of
higher acuity maternal care.
To test our hypothesis, we used a net benefit analysis.
Net benefit analysis uses the sensitivity and specificity of a
selection method but, unlike an area under the curve ana-
lysis, includes the difference in value between the benefit of
correct identification and harm of misclassification, known
as the exchange rate [8]. The exchange rate allows com-
parison of the trade-off that occurs as you reduce specifi-
city to increase sensitivity and in this way helps to
determine when a model is accurate enough to be useful.
Accounting for this trade-off is important for outcomes
such as severe maternal morbidity and mortality because
the outcomes are so rare, it is possible to have a model
with greater than 98% accuracy by identifying all women as
low risk. We used an exchange rate that matched the stat-
istical threshold for the model, that is the probability of be-
ing identified as high maternal risk by that model. This is
appropriate for epidemiologic research because it repre-
sents the exchange rate that must be accepted if the model
is used [8, 9].
The purpose of this study was to compare the net
benefit of assigning a sample of women in administrative
data as being at high maternal risk using the OCI
method or the conventional method based upon ascer-
taining the presence or absence (without weighting) of
comorbid conditions.
Methods
This study was conducted as a secondary analysis of ad-
ministrative data using a net benefit approach.
Data source
Using data files obtained from the Georgia Department
of Public Health for the years 1999 through 2012, we
constructed a retrospective cohort by deterministically
linking hospital discharge data, supplied to the Georgia
Department of Public Health from the delivery hospitals,
for all singleton delivery hospitalizations to birth, fetal
death, and maternal death certificates using a unique
maternal identifier embedded in the files by the Georgia
Department of Public Health Office of Health Indicators
for Planning. The linking methodology has been previ-
ously described [10]. All data was obtained with the
permission of the Georgia Department of Public Health
and the procedures were approved by the Emory Univer-
sity Institutional Review Board.
High risk identification models
Two models for identifying women at high maternal risk
were used to create two unique samples.
The experimental sample was created using the
weighting of 20 comorbid conditions included in the
OCI [6]. The index provides a score by summing indi-
vidual weights for each condition, the weights having
been derived from the beta coefficient in the model. The
score has been validated to improve the prediction of
maternal end organ damage compared to the Charlson
Comorbidity Index, and the OCI has been validated with
hospital discharge data in a separate sample [6, 11].
Scores for the OCI in these data ranged from 0 to 12
with a mean score of 0.55 (SD 0.90). This was different
from the score range from 0 to 19 and mean score of
0.91 (SD 1.42) in the validation cohort when the OCI
was created [6].
To use the OCI as a sample selection tool, a cut-off
value to indicate high maternal risk was selected by find-
ing the highest net benefit using a score of 2 or higher.
As this was the first test of the method, the cut-off value
was selected using the population available in these data.
While this method prevents generalizability of the cut-
off value, it was considered appropriate because the goal
of this study was to test the usefulness of the method for
sample selection, not validate the cut-off value. The cut-
off value to indicate high maternal risk status was se-
lected using net benefit analysis as defined for the main
analysis. The cut-off with the highest net benefit was a
score of four (Net Benefit of 6 per 100,000); cut-off
values less than four had negative net benefits while cut-
off values greater than four became progressively closer
to zero (See Table 1).
The comparison group was created using dichotomous
identification of any comorbid condition included in the
OCI. Dichotomous identification of any comorbidity on
a list is the method currently used to stratify fetal and
maternal risk in the literature, though the specific list of
conditions varies between studies [12, 13]. By applying
the conventional practice with the same conditions used
for the OCI, this study compared the value of identifying
risk with the index summary score rather than compar-
ing the comorbid conditions.
Comorbid conditions were identified using The Inter-
national Classification of Diseases, Ninth Revision, Clin-
ical Modification (ICD-9-CM) diagnostic codes in the
hospital discharge record, which is consistent with prior
literature addressing high maternal risk. The authors of
the OCI provided the full list of included ICD-9-CM
codes in their publication [6]. These codes were used
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without alteration for the experimental group and the
control group.
Predicted outcome
The predicted outcome for this study was poor maternal
outcome which was defined as either severe maternal
morbidity or maternal mortality. These data allowed iden-
tification of severe maternal morbidity during delivery
hospitalization using the hospital discharge record, while
maternal mortality was identified using the death certifi-
cate and included deaths up to 42 days postpartum.
Maternal mortality is the death of a woman during
pregnancy or the postpartum period. For this study, ma-
ternal mortality was limited to direct obstetric deaths as
defined by the World Health Organization and identified
by International Statistical Classification of Diseases and
Related Health Problems, 10th revision (ICD-10) codes
on the maternal death certificate [14]. The use of direct
obstetric death allows a reproducible measure of mater-
nal mortality beyond delivery hospitalization and is lim-
ited to deaths related to pregnancy.
Severe maternal morbidity was calculated using a
standard algorithm that identifies maternal end organ
damage from ICD-9-CM diagnosis and procedure codes
[15]. This algorithm updated previous lists of codes that
identified specific complications and used length of stay
less than the 90th percentile to eliminate diagnosis codes
that may have been used to “rule out” conditions. When
compared to the gold standard of medical record review,
this method had a sensitivity of 77% for identifying se-
vere maternal morbidity [16]. The most common prob-
lem with this algorithm is that the ICD-9-CM code for
transfusion has a high rate of false positive because it is
unable to discriminate between the presence of any
transfusion and the presence of a transfusion of four
units. This difference is important because transfusion
of at least four units indicates severe maternal morbidity
in the algorithm. To prevent overestimation of severe
maternal morbidity, this study did not include the ICD-
9-CM code for transfusion in the severe maternal mor-
bidity algorithm. A sensitivity analysis was performed
that included the ICD-9-CM code for transfusion to
identify the potential extent of underestimation due to
this change in calculation.
Analysis
The samples created by each method were described by
the number of women identified as being at high mater-
nal risk, along with the method’s sensitivity, specificity,
positive predictive value, accuracy, and odds ratio for a
poor maternal outcome.
The samples were compared for their ability to create
a useable research sample of women whose physical
condition would warrant transfer to a higher level of ma-
ternal care. The comparison was performed with net
benefit because, unlike assessment of accuracy or area
under the curve, net benefit analysis does not assume
the benefits and risks of misclassification are equal [9].
Net benefit was calculated using the formula
Net Benefit ¼ True Positives n−False Positives n pt
1−pt
 
where n is the total population from which the sample is
being selected and pt is the probability of being identi-
fied as high risk. In net benefit analysis, the method with
the highest net benefit is considered “superior.” A model
in which no woman is identified as high maternal risk is
represented by a net benefit of zero; so any model with a
negative net benefit indicates that model performs worse
than identifying no woman at high risk [17].
Results
Description of data
The study sample for years 2008–2012 included 550,237
unique delivery hospitalizations. The mean maternal age
was 27.04 years (SD 6.1) and the mean gestational age at
delivery was 38.7 weeks (SD 2.2). Of these hospitaliza-
tions, 2654 (0.5%) were identified as having a poor ma-
ternal outcome.
The most common conditions identified by the OCI
were previous cesarean delivery (17%), age 35–39
years (9.4%), and gestational hypertension (4.5%). The
sensitivity of each comorbidity at predicting poor ma-
ternal outcome ranged from 0.6% for previous
cesarean delivery and gestational hypertension, to
22.6% for chronic congestive heart failure. Full de-
scription is available in Table 2.
Table 1 Results of net-benefit analysis to select a cut-off value for the obstetric comorbidity index
Cut-off value Sensitivity Specificity Positive predictive value Net benefit per 1000 live births
2 0.52 0.87 0.02 − 185.7
3 0.38 0.96 0.04 −0.17
4 0.16 0.99 0.06 0.63
5 0.16 0.99 0.08 0.33
6 0.03 0.99 0.09 0.12
7 0.01 0.99 0.12 0.05
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Model characteristics
The experimental sample, using the OCI, identified 7260
(1.3%) women at high maternal risk. This compared to
193,247 (35.1%) women identified at high maternal risk
in the control sample by unweighted OCI. The samples
varied greatly in their sensitivity and specificity, though
both models had a low sensitivity. The experimental
sample had the lowest sensitivity (16.4%) but the highest
specificity (98.7%) and was the most accurate (98%). Full
model characteristics are available in Table 3.
In the net benefit analysis, the experimental sample cre-
ated using a cut-off value with the OCI (net benefit 0.7) was
superior to the comparison sample built using the conven-
tional sample selection. The control model resulted in nega-
tive net benefit which indicated it created a research sample
that was worse than identifying no women as high risk. The
Table 2 Distribution of conditions included in the obstetric comorbidity index among women delivering in Georgia, 2008–2012
Total n = 550,237 Rate per 1000 deliveries Women with poor maternal outcome n = 2654
Previous cesarean delivery 93,634 170.2 648 (24.4%)
Maternal age (years)
Older than 44 673 1.22 12 (0.4%)
40–44 12,499 22.72 136 (5.1%)
35–39 57,879 105.19 429 (16.2%)
Gestational hypertension 24,632 44.77 150 (5.7%)
Mild or unspecified preeclampsia 16,350 29.71 332 (1.2%)
Asthma 12,159 22.10 87 (3.2%)
Severe Preeclampsia or Eclampsia 7062 12.8 550 (20.7%)
Pre-existing diabetes mellitus 4638 8.43 87 (3.3%)
Drug abuse 3947 7.17 39 (1.5%)
Pre-existing hypertension 2471 4.49 100 (3.8%)
Placenta previa 2439 4.43 117 (4.4%)
Cardiac valvular disease 2073 3.77 32 (1.2%)
Chronic renal disease 1258 2.29 81 (3.1%)
HIV 974 1.77 7 (0.3%)
Sickle cell disease 875 1.59 114 (4.3%)
Systemic lupus erythematosus 601 1.09 14 (0.5%)
Multiple gestationa 588 1.07 7 (0.3%)
Congenital heart disease 374 0.68 12 (0.5%)
Alcohol Abuse 272 0.49 4 (0.2%)
Pulmonary hypertension 88 0.16 13 (0.5%)
Chronic ischemic heart disease 71 0.13 2 (0.1%)
Chronic congestive heart failure 31 0.05 7 (0.3%)
aData was limited to singleton delivery by birth certificate
Table 3 Accuracy and net benefit of high maternal risk models to predict severe maternal morbidity or direct obstetric death
Obstetric comorbidity index Unweighted comorbidities
Total High Risk 7260 (1.3%) 193,247 (35.1%)
True Positives 436 1588
Sensitivity 16.4% 59.8%
Specificity 98.7% 65%
Accuracy 98% 65%
Positive Predictive Value 6% 0.8%
Negative Predictive Value 99.6% 99.7%
OR (95% CI) 15.6 (14.0, 17.3) 2.8 (2.6, 3.0)
Net Benefit 0.7 −185.7
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OCI with a cut-off value of 4 remained the superior risk
identification method in the sensitivity analysis.
Discussion
To our knowledge, this is the first study that compared
the value of methods to create a sample of women at
high maternal risk in administrative data. In this ana-
lysis, the experimental sample created with the OCI
using a cut-off value of 4 had a positive net benefit. This
appears to be due to the high specificity of the weighted
scoring of the OCI. The conventionally derived sample
had a negative net benefit, which means it was less valu-
able than creating a sample by identifying no woman as
having high maternal risk. In the case of a research sam-
ple, a negative net benefit means it is likely that the
harm due to misclassification of women as having high
maternal risk outweighed the benefit of correctly identi-
fying women at high maternal risk. Misclassification bias
would skew the result of any study toward no difference,
and therefore increase the risk of a Type II error.
Though the conventional method of sample selection
had better sensitivity, the low specificity of this method
resulted in high proportions of women classified at high
maternal risk. Given that only 0.5% of women in these
data experienced a poor maternal outcome, identifica-
tion of 35% of the women as being at high maternal risk
is likely the result of overestimation of risk status.
Though the women identified with these methods may
have had an elevated risk, it is unlikely such high pro-
portions of women would be transferred to the highest
acuity care to prevent maternal complications. It is more
likely most of these women represent a category of mod-
erate maternal risk rather than high risk.
Categorization as women at moderate maternal risk
may better simulate clinical reasoning about care than a
dichotomous categorization as either low or high risk.
Women at moderate maternal risk likely received a
higher level of surveillance with their obstetrician rather
than being transferred to a sub-specialty practice. In
these data, the OCI identified 190,672 (35%) women
who might be considered moderate risk; that is, they had
a comorbid condition but did not meet the threshold for
high maternal risk identification. Stratification of admin-
istrative data into low, moderate, and high maternal risk
provides an opportunity to better understand the impli-
cations of health system level interventions to prevent
maternal morbidity and mortality.
In these data, the conventional model identified 35%
of the sample as being at high maternal risk but cap-
tured 60% of the poor maternal outcomes. This is con-
cerning as it suggests 40% of the severe maternal
morbidity and mortality occurred in women with no
coded ICD-9-CM risk factors. It is beyond the ability of
this study to determine if risk factors were identified by
clinicians but not coded in the hospital discharge record.
Additional work is needed to improve identification of
maternal risk factors in administrative data.
The low positive predictive value of both models indi-
cates poor overall performance which limits the clinical
usability for identification of women at high maternal
risk in this population. However, the high specificity of
the model suggests the potential for use in clinical iden-
tification of women at low maternal risk. Interpretation
of the predictive value of a model depends on the under-
lying prevalence of the condition in the population. The
low prevalence of maternal morbidity and mortality in
this population results in a lower positive predictive
value and higher negative predictive value than may be
identified in populations with a higher prevalence of
poor maternal outcomes.
Limitations
The methods tested in this paper rely on ICD-9-CM
codes, which may not reflect the true distribution of co-
morbid conditions or clinically important outcomes in
the community. Additionally, ICD-9-CM codes are an
imprecise representation of the clinical condition of a
patient, which will affect both scoring of risk and identi-
fication of clinical outcomes. For example, administra-
tive data records only include that gestational diabetes
was present, not if it was well controlled. This limitation
was considered acceptable for this study because these
limitations exist in all administrative data sets, but ad-
ministrative data is necessary for population level stud-
ies. While this method was found to be useful for
defining research samples, the results from these data
are not generalizable to risk identification in clinical
practice and should not be considered a validation for
control of confounding or in clinical use.
This study was delimited to risk identification methods
that relied on comorbid conditions already known to in-
crease maternal risk, and validated as part of the OCI.
Other maternal characteristics are believed to increase
risk, but were not included in this study because this
study tested a method of sample selection with a vali-
dated index. It is possible another risk identification
model not tested in this study, such as the Pregnancy
Risk Score System, is superior to the OCI as a sample
selection tool [5]. It is also possible that inclusion of
other criteria, not included in the risk identification
model used, would create a superior model.
To use the OCI as a sample selection tool rather than
to control for confounding, a cut-off value was selected.
The cut-off was selected using net benefit analysis to en-
sure the comparison of the value of the index was not
hindered by assigning a random cut-off. Though the
cut-off of 4 was superior for these data, this cut off is
unlikely to be generalizable. These data were limited to
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singleton deliveries and appeared to include underre-
porting of some outcomes such as alcohol abuse. In
these data, although singleton delivery was identified
using the birth certificate, 588 records were identified as
multiple gestation through ICD-9-CM code in the linked
discharge record. These data are not able to determine
which source of data, hospital discharge or birth certifi-
cate, was accurate in these cases. Underreporting of al-
cohol abuse has been reported previously, which
suggests this variable may be an inherent limitation to
use of the index in administrative data [11]. It is likely
that the distribution of risk scores, and potentially the
superior cut-off value, would be different if these data
included all multiple deliveries or had different patterns
of comorbidity reporting. Researchers using sample se-
lection with the OCI should assess the best cut-off value
for the study data and report the cut-off used and ra-
tionale until a standard is determined.
This study relied on net benefit analysis because it
allowed comparison of the accuracy of the model
while accounting for the unequal value of true
positives and false positives when trying to minimize
misclassification bias. Accounting for unequal value is
the reason the OCI was superior for sample selection
despite a lower sensitivity. Net benefit analysis was
useful for comparing models for sample selection, but
did not assess the diagnostic accuracy of the models.
Diagnostic accuracy, as measured by the area under
the curve, treats true positives and false positives as
equal and therefore would have a different result. The
results of this study should not be interpreted as a
validation of the OCI for diagnostic reasoning.
Finally, this study compared methods of risk identifica-
tion by assessing the accuracy of the method at identify-
ing women who had a poor maternal outcome.
However, the goal of identifying women at high mater-
nal risk is to ensure they receive the necessary care to
prevent poor maternal outcomes. This study is not able
to account for the care women did or did not receive
that, if controlled, may alter the value of the models.
This limitation was considered acceptable because these
data represent clinically identified risk and the associated
outcomes with the available medical practice.
Conclusions
The present findings highlight the usefulness of the OCI
as a tool to select a sample of women at high maternal
risk in administrative data. The OCI was superior to the
conventional practice of identifying women with any co-
morbid condition. Additionally, the OCI allowed identi-
fication of a group of women at moderate maternal risk;
that is women with identified risk factors but not likely
to need transfer to the highest acuity care to prevent
poor maternal outcomes. This improved stratification of
risk can prevent misclassification bias. Researchers who
use the OCI should be aware of the potential for under-
reported conditions and therefore select the cut-off
based on the data being analyzed.
Of particular concern to the authors is that the comor-
bidities used to identify risk in these models were unable
to achieve higher than 60% sensitivity. This is an import-
ant finding as it may indicate either the current under-
standing of maternal risk or the current recording of
comorbid conditions in administrative data are not pre-
cise enough to create a standard research definition that
will prevent misclassification bias during sample selec-
tion. In addition to the lack of clinical specificity, the
variation in rate of false positives and false negatives for
ICD-9-CM codes during delivery admissions provide
additional challenges to using administrative data [18].
There are likely non-random reasons for both missing
and mis-coded ICD-9-CM codes that may hinder inter-
pretation of findings when risk is measured by ICD-9-
CM coding. Further research is needed to identify the
best list of comorbidities or other maternal characteris-
tics that predict maternal high risk.The conventional
method of maternal risk stratification grew from im-
proved understanding of characteristics associated with
poor maternal outcomes. These characteristics are clas-
sified as “risk factors” due to increase in relative risk and
used to define high maternal risk in administrative data
without consideration of the absolute risk. When apply-
ing definitions of maternal risk to sample selection in
administrative data, understanding how inclusion of add-
itional criteria decreases specificity, accuracy, and net
benefit of maternal risk identification is important to
preventing misclassification bias. Future research should
continue to compare the usefulness of maternal risk
stratification methods for administrative data, comparing
net benefit of the methods in different study populations
and evaluating the impact of misclassification of risk on
estimation of benefit for population level interventions.
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